Mohamed Shelan

Assistant Professor

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Collaborators (6)

Nikolaos KOUTSOUVELIS

University Hospital of Geneva

Raphaël Moeckli

Robert Foerster

University of Zurich

Mauricio Reyes

Associate Professor

University of Bern

P Niehoff

Arnoud Templeton

University of Basel

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mohamed Shelan

Research Interests

Explore related searches

Contact this professor

Articles (19)

Collaborators (6)

Nikolaos KOUTSOUVELIS

Raphaël Moeckli

Robert Foerster

Mauricio Reyes

P Niehoff

Arnoud Templeton

Make your next move.

Mohamed Shelan

Research Interests

Explore related searches

Contact this professor

Articles (19)

Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials

Delayed definitive management of localized prostate cancer: what do we know?

Orchestrating explainable artificial intelligence for multimodal and longitudinal data in medical imaging

Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?

Focal brachytherapy as definitive treatment for localized prostate cancer: A systematic review and meta-analysis

Safety of Ultrahypofractionated Pelvic Nodal Irradiation in the Definitive Management of Prostate Cancer: Systematic Review and Meta-analysis

HypoFocal SRT Trial: Ultra-hypofractionated focal salvage radiotherapy for isolated prostate bed recurrence after radical prostatectomy; single-arm phase II study; clinical trial protocol

Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study.

PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.

Dose-Volume Histogram Parameters and Quality of Life in Patients with Prostate Cancer Treated with Surgery and High-Dose Volumetric-Intensity-Modulated Arc Therapy to the Prostate Bed

Five Fractions Versus Seven Fractions SBRT for Intermediate- and High-Risk Prostate Cancer: A Propensity Score Matched Pair Analysis

VoiceS: voice quality after transoral CO<sub>2</sub> laser surgery versus single vocal cord irradiation for unilateral stage 0 and I glottic larynx cancer-a randomized phase III trial.

Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer.

[Multimodality treatment in high-risk and very high-risk prostate cancer: outcomes from international phase III randomized controlled trials].

Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.

Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries

Impact of pretreatment second look <sup>18</sup>FDG-PET/CT on stage and treatment changes in head and neck cancer.

[Virtual prostatectomy using single dose radiotherapy].

[Single dose of 24 Gy or 3-fraction SBRT regimen in the treatment of oligometastatic cancer? : A phase III multi-center trial].

Collaborators (6)

Nikolaos KOUTSOUVELIS

Raphaël Moeckli

Robert Foerster

Mauricio Reyes

P Niehoff

Arnoud Templeton

Make your next move.

[Single dose of 24 Gy or 3-fraction SBRT regimen in the treatment of oligometastatic cancer? : A phase III multi-center trial].